Disclosure: This blog is for informational purposes only
In contrast to findings with behavioral 20,21,22 and other pharmacological interventions 10,12,13 , the similar mean weight loss achieved with semaglutide 2.4 mg in STEP 5 at weeks 52 and 104 (15.6% and 15.2%, respectively) suggests that, on average, there is minimal weight regain over 104 weeks when once-weekly semaglutide therapy is continued
More longitudinal studies, adequately considering possible confounding factors, are needed to clarify these relationships and identify modifiable risk factors for targeted interventions
Weight loss plateaus represent the most common trigger
The rate of weight loss with Semaglutide GLP-1 varies from patient to patient and is influenced by factors such as starting weight, dosage, dietary habits, and overall lifestyle